News

Issue of the week: the motor finance ruling ...

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Intel under pressure: US president Donald Trump backtracked on his criticism of chipmaker Intel’s CEO, Lip-Bu Tan (pictured), hailing Tan as a “success” after meeting him at the White House. Days earl

Accenture’s CEO has quietly built the consulting company into a go-to expert on mastering AI. But can she save her industry from being replaced by robots?

Artificial intelligence (AI) is – if you ask any of Silicon Valley’s top CEOs – the biggest opportunity in their company’s history. Few will tell you that it’s also their biggest threat. “For those bi

CITY